RE: AZ vaccine impact on OXB?16 Nov 2020 11:43
I have wondered aloud on here a few times about this and have found no definite information on which to make an informed judgement.
My guess, and it is no more than that, but reinforced by what Shatter has found about India, is that like AZ we are probably doing at cost or a very low margin.
It of course accelerated Oxbox and is enabling us to prove the manufacturing works but impact on profit, as opposed to cashflow, could be minimal.
It would seem strange if OXB was the only company in this loop making a good margin.
As I say just musings and guess work and would be happy to be proven wrong except from a worldwide pov the cheaper the vaccine is the better. It then has to be distributed and the populations vaccinated so logistics will be the key in the end and the UK government's track record to date is uninspiring to say the least.